Affiliation:
1. From the Kimmel Cancer Institute, Thomas Jefferson Medical College, Philadelphia, PA; and Department of Biomedical Sciences, University of Modena and Reggio Emilia Medical School, Modena, Italy.
Abstract
Abstract
The CCAAT/enhancer binding protein-α (C/EBPα) is a transcription factor required for differentiation of myeloid progenitors. In addition to specific DNA binding, C/EBPα is also involved in protein-protein interactions, some of which (p21, Cdk2/Cdk4, E2F) appear to be required for inhibition of proliferation and possibly differentiation. To investigate the mechanisms of C/EBPα-induced granulocytic differentiation, we generated C/EBPα mutants reportedly defective in DNA binding, transactivation, and Cdk2/Cdk4 and E2F interaction and assessed their effects in a myeloid precursor cell line, primary bone marrow and C/EBPα knockout fetal liver precursor cells. We show here that the DNA binding–deficient Lys298Glu mutant, the E2F binding–deficient basic region mutant 2 (BRM-2) carrying the Ile294Ala and Arg297Ala substitutions, and the transactivation-deficient N-terminus truncated p30 mutant all fail to promote differentiation on ectopic expression in myeloid precursor cells. By contrast, ectopic expression of the Cdk2/Cdk4 interaction–deficient Δ177-191 mutant promotes differentiation and induces gene expression as effectively as wild-type C/EBPα. Thus, the integrity of the transactivation and DNA binding domains, but not of the Cdk2/Cdk4 interaction region, is necessary for C/EBPα-induced differentiation. Since the E2F binding–deficient BRM-2 mutant interacted with E2F-1 but failed to activate gene expression, our results lend support to the hypothesis that activation of gene transcription is the determining factor in C/EBPα-dependent differentiation.
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Cited by
82 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献